Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 25,319 CGEM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 25,319 | n/a |
| Jun 12, 2026 | uniQure N.V. (QURE) | Grant/Award | 7,550 | n/a |
| Jun 24, 2025 | uniQure N.V. (QURE) | Sale | 2,112 | $30.5K |
| Jun 16, 2025 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 38,513 | n/a |
| Jun 13, 2025 | uniQure N.V. (QURE) | Grant/Award | 7,970 | n/a |
| Jun 21, 2024 | uniQure N.V. (QURE) | Grant/Award | 8,080 | n/a |
| Jun 17, 2024 | uniQure N.V. (QURE) | Sale | 2,229 | $11.4K |
| Jun 4, 2024 | Fusion Pharmaceuticals Inc. (FUSN) | Disposition to Issuer | 34,000 | n/a |
| May 16, 2024 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 15,618 | n/a |
| Jun 20, 2023 | uniQure N.V. (QURE) | Grant/Award | 8,700 | n/a |